The Safety of Antirheumatic Drugs (11.02.2022)
Does treatment strategy influence the ability to achieve and sustain DMARD-free remission in patients with RA? Results of an observational study comparing an intensified DAS-steered treatment strategy with treat to target in
Drugs used for arthritis. Conventional Disease Modifying Anti-Rheumatic... | Download Scientific Diagram
Frontiers | The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions
The Korean Journal of Internal Medicine
Traditional disease-modifying antirheumatic drugs (DMARDs) | Download Table
Biomolecules | Free Full-Text | Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics
Medicina | Free Full-Text | Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents
Emerging Treatments for Rheumatoid Arthritis: Update | Consultant360
Comparative Cost-Effectiveness of Tofacitinib With Continuing Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs for Active Rheumatoid Arthritis in South Korea | Rheumatology and Therapy
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis | Annals of the Rheumatic Diseases
Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid Arthritis | Rheumatology and Therapy
Disease-Modifying Antirheumatic Drug - an overview | ScienceDirect Topics
JCM | Free Full-Text | Current Therapeutic Options in the Treatment of Rheumatoid Arthritis
Patient disposition. DMARD, disease-modifying antirheumatic drug; mITT,... | Download Scientific Diagram
Conventional disease‐modifying antirheumatic drugs to treat rheumatoid arthritis - Rath - 2011 - Drug Development Research - Wiley Online Library
Disease-modifying antirheumatic drugs | Download Table
Phytochemical add-on therapy to DMARDs therapy in rheumatoid arthritis: In vitro and in vivo bases, clinical evidence and future trends - ScienceDirect
Treatment of Juvenile Idiopathic Arthritis | Pediatric Annals
Biomedicines | Free Full-Text | DNA Methylation Signatures of Response to Conventional Synthetic and Biologic Disease-Modifying Antirheumatic Drugs ( DMARDs) in Rheumatoid Arthritis
:max_bytes(150000):strip_icc()/dmards-5200573_final-d7a3435040364245b453126ef7ee6572.jpg "DMARDs for Rheumatoid Arthritis: Types, Uses, Dosages,")
DMARDs for Rheumatoid Arthritis: Types, Uses, Dosages,
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs | Annals of the Rheumatic Diseases
Emerging Treatments for Rheumatoid Arthritis: Update | Consultant360
Facilitators and Barriers to Adherence in the Initiation Phase of Disease-modifying Antirheumatic Drug (DMARD) Use in Patients with Arthritis Who Recently Started Their First DMARD Treatment | The Journal of Rheumatology
